The candidate's long-term career goal as a physician-scientist is to conduct investigator-initiated research into the molecular basis of the human immune response to viruses. Immediate goals include acquisition of skills in molecular virology and immunology studies in animals. These skills are critical to complement the candidate's extensive training in molecular human immunology acquired during previous studies of the human antibody response to respiratory syncytial virus (RSV). The experience gained during this project will prepare the candidate broadly to conduct unique studies of the immunobiology of early childhood pathogens. Human metapneumovirus (hMPV) is a newly described paramyxovirus that infects most humans by the age of five years. Our preliminary data indicate that hMPV is a major cause of lower respiratory tract infection (LRI) in children with a spectrum of illness and morbidity similar to that of RSV. This work proposes to define the antigenic determinants of protective immunity to hMPV, providing foundational new knowledge about the host immune response to this important emerging pathogen. The central hypothesis of this proposal is that the hMPV surface glycoproteins F (fusion) and G (attachment) are the major determinants of protective immunity and that protection is mediated by humoral antibody.
Specific aim #1 is to investigate the antibody response to hMPV F and G proteins expressed in a novel vaccinia-virus based mammalian system. These recombinant antigens will be critical tools to evaluate the host immune response to hMPV.
Specific aim #2 is to determine whether hMPV F and G surface proteins expressed by recombinant vaccinia virus are major protective antigens in a rodent model. These experiments will identify the determinants of protective immunity and define antigenic diversity between hMPV strains.
Specific aim # 3 is to determine if humoral antibody alone is sufficient to mediate protection against recurrent LRI caused by hMPV. This work will provide valuable new data regarding the host immune response to an important respiratory pathogen of childhood that will be applicable to studies of human immunopathology associated with hMPV infection. The elucidation of the mechanism of protective immunity will also be important for future development of potential vaccines. The proposed work will provide the candidate skills and experience to be an outstanding physician-scientist in the field of human viral immunology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08AI056170-03
Application #
6929356
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Rubin, Fran A
Project Start
2003-08-01
Project End
2006-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
3
Fiscal Year
2005
Total Cost
$119,286
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pediatrics
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Ryder, Alex B; Tollefson, Sharon J; Podsiad, Amy B et al. (2010) Soluble recombinant human metapneumovirus G protein is immunogenic but not protective. Vaccine 28:4145-52
Tollefson, Sharon J; Cox, Reagan G; Williams, John V (2010) Studies of culture conditions and environmental stability of human metapneumovirus. Virus Res 151:54-9
Cseke, Gabriella; Maginnis, Melissa S; Cox, Reagan G et al. (2009) Integrin alphavbeta1 promotes infection by human metapneumovirus. Proc Natl Acad Sci U S A 106:1566-71
Derdowski, Aaron; Peters, Timothy R; Glover, Nancy et al. (2008) Human metapneumovirus nucleoprotein and phosphoprotein interact and provide the minimal requirements for inclusion body formation. J Gen Virol 89:2698-708
Cseke, Gabriella; Wright, David W; Tollefson, Sharon J et al. (2007) Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J Virol 81:698-707
Miller, Scott A; Tollefson, Sharon; Crowe Jr, James E et al. (2007) Examination of a fusogenic hexameric core from human metapneumovirus and identification of a potent synthetic peptide inhibitor from the heptad repeat 1 region. J Virol 81:141-9
Williams, John V; Chen, Zhifeng; Cseke, Gabriella et al. (2007) A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo. J Virol 81:8315-24
Williams, John V; Tollefson, Sharon J; Johnson, Joyce E et al. (2005) The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity. J Virol 79:10944-51